Abraham Kim[email protected]Radiologic TechnologistStudy questions whether x-rays really need to be repeatedCurrent radiology practice gives radiologic technologists significant leeway in deciding whether to retake radiographs that might not be up to snuff. But should the weight of that decision rest on their shoulders alone? Researchers investigated the question in a September 12 study published in the American Journal of Roentgenology.September 18, 2017Practice ManagementCoordinator service bolsters radiologists' efficiencyBurnout among radiologists is on the rise, with one of the principal contributing factors being workplace inefficiency. What measures are being taken to address this pressing issue? Researchers from NYU Langone Medical Center offer one solution in a paper published online September 9 in the Journal of the American College of Radiology.September 17, 2017CTStudy questions value of CT scans after NCSLC surgeryPerforming frequent CT scans after surgery for non-small cell lung cancer (NSCLC) may not necessarily improve overall patient survival rates, according to findings presented at the European Society for Medical Oncology 2017 congress in Madrid.September 14, 2017Previous PagePage 63 of 63Top StoriesCTNew benchmark helps monitor cumulative CT radiation doseThe findings highlight the need for systematic dose tracking and rigorous justification of imaging.Radiation Oncology/TherapyStudy questions routine use of radiotherapy after bone surgeryUltrasoundCEUS outshines color Doppler imaging for indeterminate kidney lesionsWomens ImagingWomen's Imaging MinnieCast, Episode 2: Risk-based vs. annual mammography screening, part 1Digital X-RayChest x-rays reveal atherosclerosis in patients undergoing amputations
![Images depict axial MRI scans in a 50-year-old premenopausal female patient with biopsy-proven 12-mm invasive lobular cancer in the lower outer quadrant of the left breast. Upper images are subtracted dynamic contrast-enhanced (DCE) MRI scans from the first and second postcontrast acquisitions. Lower images are ultrafast MRI scans obtained within 24 hours after the DCE study (four consecutive subtracted dynamic frames from time points [T] 6–9). There is marked background parenchymal enhancement (BPE) on the DCE MRI scans. Thus, the known cancer (arrow) is barely visible; it exhibits only slightly stronger enhancement than the normal fibroglandular tissue, which results in low conspicuity. At ultrafast MRI there is less BPE, and still the cancer is barely visible because it starts to enhance simultaneously with the BPE. The conspicuity of the cancer is even reduced compared with the DCE series. Both of the readers missed this cancer on both the DCE and ultrafast MRI scans.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2025/05/2025-05-06-rsna-ultrafast-dce-mri-breast.Gzvq76udFr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
